Organon & Co. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Organon & Co. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2020 to Q3 2024.
  • Organon & Co. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $1.69B, a 2.25% increase year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.69B +$37M +2.25% Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $1.62B -$55M -3.29% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.55B +$102M +7.06% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.74B +$269M +18.2% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $1.65B +$208M +14.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.67B +$182M +12.2% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.45B +$123M +9.3% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $1.48B +$93M +6.73% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $1.44B -$58M -3.87% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.49B -$17M -1.13% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $1.32B +$312M +30.9% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.38B +$344M +33.1% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $1.5B Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.51B Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $1.01B Mar 31, 2021 10-Q 2021-06-21
Q4 2020 $1.04B Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.